Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2CNS 2Sarcoma 1Plasma cell 1Genitourinary 1Dermatologic 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 78Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Myelodysplastic Syndromes 59Leukemia, Lymphocytic, Chronic, B-Cell 56Lymphoma, Non-Hodgkin 55Multiple Myeloma 52Hodgkin Disease 52Leukemia 48Lymphoma, Mantle-Cell 43Lymphoma 39Lymphoma, Follicular 38Leukemia, Myelogenous, Chronic, BCR-ABL Positive 38Myeloproliferative Disorders 36Lymphoma, B-Cell, Marginal Zone 36Lymphoma, Large B-Cell, Diffuse 35Burkitt Lymphoma 34Leukemia, Myelomonocytic, Chronic 30Congenital Abnormalities 30Lymphoma, Large-Cell, Immunoblastic 27Waldenstrom Macroglobulinemia 26Leukemia, Myeloid, Accelerated Phase 25Leukemia, Myeloid, Chronic-Phase 23Hematologic Neoplasms 22Blast Crisis 22Primary Myelofibrosis 21Anemia, Refractory, with Excess of Blasts 21Dendritic Cell Sarcoma, Interdigitating 20Lymphoma, T-Cell, Cutaneous 18Lymphoma, Large-Cell, Anaplastic 18Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17

Interventions

Cyclophosphamide 21Isotretinoin 14Etoposide 13Topotecan 12Irinotecan 12dinutuximab 10Temozolomide 10Magnetic Resonance Spectroscopy 10Doxorubicin 10Melphalan 9sargramostim 8Vincristine 8Filgrastim 7Cisplatin 7Specimen Handling 6Granulocyte-Macrophage Colony-Stimulating Factor 6Granulocyte Colony-Stimulating Factor 6Carboplatin 63-Iodobenzylguanidine 6X-Rays 5Phantoms, Imaging 5Busulfan 5Biopsy 5fludarabine 4etoposide phosphate 4aldesleukin 4Thiotepa 4Stem Cell Transplantation 4Radiotherapy 4Nuclear Medicine Department, Hospital 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Neuroblastoma × Whole-Body Irradiation × Clear all
NCT00536601 2021-04-22

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

Roswell Park Cancer Institute

Phase NA Completed
174 enrolled 17 charts
CNSDermatologicGenitourinaryLymphoidOther hematologic neoplasmPlasma cellSarcoma

Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Neuroblastoma, Recurrence, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Neuroectodermal Tumors, Primitive, Peripheral, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating, Intraocular Lymphoma

NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated
1 enrolled 8 charts
CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡